Podiatrists in Bastrop, TX Accepting Medicare

2 Podiatrists found. Showing 1 - 2

James Handy Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3101 Hwy 71 E, Ste #211, Bastrop, TX 78602 Phone: 512-321-0000    Fax: 512-321-1699

James Handy Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3101 Highway 71 E, Ste#211, Bastrop, TX 78602 Phone: 512-321-0000    Fax: 512-321-1699

News Archive

Medic Vision announces introduction of SafeCT Dose Reporting for healthcare providers

Medic Vision Imaging Solutions, Ltd., the leading innovator of vendor-independent image enhancement solutions for low-dose CT exams, announced today the introduction and availability of SafeCT Dose Reporting. Healthcare facilities can now, for the first time, use a single software platform to meet their low dose CT imaging needs while also conforming to CT dose monitoring and reporting standards.

Studies reveal strategies for using shingles vaccine in arthritis patients

New research indicates that the live varicella-zoster vaccine-which is given to protect against shingles-elicits robust immune responses in patients when administered several weeks prior to the start of treatment with the arthritis drug tofacitinib.

Notch activation determines signals necessary to generate hematopoietic stem cells in laboratory

An international study led by researchers from IMIM (Hospital del Mar Medical Research Institute) published in the journal Nature Communications has revealed that the intensity or efficiency of the activation of a protein called Notch, which is involved in the different phases of embryonic development, determines the fate of cells, i.e. if cells will form the aorta artery or blood (hematopoietic) stem cells. For artery cells, many Notch molecules need to be activated, whereas for hematopoietic cells many fewer are needed.

Curis presents data on CU-906 compound designed to inhibit HDAC and PI3K/mTOR targets simultaneously

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that data provided in a presentation entitled, "Antitumor activity of single small molecule agent targeting PI3K/mTor and HDAC," were presented at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010, which is being held in Washington, DC April 17-21.

Read more Medical News

› Verified 3 days ago